ENDOTHELIAL FUNCTION IN PATIENTS WITH COPD AND CARDIOVASCULAR DISEASE
PDF

Keywords

chronic obstructive pulmonary disease, hypertension, coronary artery disease, heart failure, nitric oxide, endothelin-1, intercellular adhesion molecule-1, 8-isoprostane.

Abstract

Cardiovascular pathology is one of the frequent comorbidities in patients with chronic obstructive pulmonary disease, due to both genetic predisposition and common risk factors (smoking, senile age, male gender, sedentary lifestyle, obesity). The article shows that development of endothelial dysfunction is one of the earliest phases of pathogenesis in this setting. Endothelial dysfunction mechanisms are defined and characterized, including an imbalance of vasoconstricting and vasodilating agents with the emergence of "vicious circles" that violate hemo-vascular homeostasis. The role of nitric oxide, endothelin-1, intercellular adhesion molecule-1 (ICAM-1) in the development of endothelial dysfunction in COPD patients is discussed.

The article defines the concept of oxidative stress, the most potent oxidants and mechanisms of their damaging effect arebeing listed. A particular attention is paid to 8-isoprostane as a golden standard in assessment of oxidative stress in patients with COPD .

 

https://doi.org/10.35339/ic.8.3.144-151
PDF

References

References

Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., ... & Buist, S. (2006). Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal, 27(2), 397-412. doi.org/10.1183/09031936.06.00025805

Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine, 3(11), e442. doi.org/10.1371/journal.pmed.0030442

Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., ... & Blanc, P. D. (2003). The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal, 22(3), 462-469. doi.org/10.1183/09031936.03.00094203

Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., ... & Kramer, B. (2010). Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax, 65(6), 473-479. doi.org/10.1136/thx.2009.125435

Feshhenko, Ju. I. (2009). HOZL v Ukraine: problemy i puti reshenija. Zdorov’ja Ukraїni, 9(1), 3−4 (in Russian).

Global'naja strategija diagnostiki, lechenija i profilaktiki HOBL. Peresmotr 2011 g. Per. s angl. / pod red. A.S. Belevskogo. M.: Rossijskoe respiratornoe obshhestvo, 2012. 80s. [Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for Diagnosis, Management and Prevention for Chronic Obstructive Lung Diseases (Revised 2011). Rossiyskoe Respiratornoye Obschestvo Publ., 2012 (in Russian)].

Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008). Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal, 32(4), 962-969. doi.org/10.1183/09031936.00012408

Ovcharenko, S. I. (2018). Serdechno-sosudistaja patologija u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih: kak my lechim?. RMZh, 26(10-1), 36-39 [Ovcharenko, S.I. (2018). Cardiovascular pathology in patients with chronic obstructive pulmonary disease: how do we treat it? RMJ. 10 (I), 36–39] (in Russian).

Babak, O. Ja., Shaposhnikova, Ju. N., & Nemcova, V. D. (2004). Arterial'naja gipertenzija i ishemicheskaja bolezn' serdca-jendotelial'naja disfunkcija: sovremennoe sostojanie voprosa. Ukrainskij terapevticheskij zhurnal, (1), 14-22.

Chuchalin, A. G. (2008). Hronicheskaja obstruktivnaja bolezn' legkih i soputstvujushhie zabolevanija. Pul'monologija, (2), 5-14 (in Russian).

Feary. J, & Branes N. (2009). Abstract, ERS, 19 Annual Congress. sept.13. P. 962.

Brodskaja, T. A., Nevzorova, V. A., Gelcer, B. I., & Motkina, E. V. (2007). Jendotelial'naja disfunkcija i bolezni organov dyhanija. Terapevticheskij arhiv, 79(3), 76-84 (in Russian).

Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012). Oxidative stress and antioxidant defense. World Allergy Organization Journal, 5(1), 9-19.doi.org/10.1097/wox.0b013e3182439613

Kovaljova, O. N., Ashcheulova, T. V., Gerasimchuk, N. N., & Safargalina-Kornilo-va, N. A. (2015). Rol'oksidativnogo stressa v stanovlenii i progressirovanii gipertonicheskoj bolezni [Role of oxidative stress in the formation and progression of hypertensive disease]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 29(4(201)), 5-10 (in Russian).

Rahman, I., & Adcock, I. M. (2006). Oxidative stress and redox regulation of lung inflammation in COPD. European respiratory journal, 28(1), 219-242. doi.org/10.1183/09031936.06.00053805

Yin, H. (2008). New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo. Biofactors, 34(2), 109-124. doi.org/10.1002/biof.5520340203

Herasymchuk, N. (2018). 8-isoprostane as the main marker of oxidative stress. Zaporozhye medical journal. Volume 20. No. 6 (11), 2018, - 853-859. doi.org/10.14739/2310-1210.2018.6.146780

Horváth, I., Hunt, J., & Barnes, P. J. (2005). Exhaled breath condensate: methodological recommendations and unresolved questions.

European Respiratory Journal,26(3), 523-548. doi.org/10.1183/09031936.05.00029705

Kostikas, K., Papatheodorou, G., Psathakis, K., Panagou, P., & Loukides, S. (2003). Oxidative stress in expired breath condensate of patients with COPD. Chest, 124(4), 1373-1380. doi.org/10.1378/chest.124.4.1373

Montuschi, P., Collins, J. V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S. A., & Barnes, P. J. (2000). Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. American journal of respiratory and critical care medicine, 162(3), 1175-1177.doi.org/10.1164/ajrccm.162.3.2001063

Antczak, A., Ciebiada, M., Pietras, T., Piotrowski, W. J., Kurmanowska, Z., & Górski, P. (2012). Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease. Archives of medical science: AMS, 8(2), 277-285. oi.org/10.5114/aoms.2012.28555

Biernacki, W. A., Kharitonov, S. A., & Barnes, P. J. (2003). Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax, 58(4), 294-298. doi.org/10.1136/thorax.58.4.294

Anaev, Je. H., Kushaeva, M. Je., & Kurova, V. S. (2012). Znachenie proteomnogo analiza kondensata vydyhaemogo vozduha pri diagnostike HOBL i pnevmonii. Pul'monologija. 5, 5–9.

Ko, F. W., Lau, C. Y., Leung, T. F., Wong, G. W., Lam, C. W., & Hui, D. S. (2006). Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respiratory medicine, 100(4), 630-638. doi.org/10.1016/j.rmed.2005.08.009

Wanner, A., & Mendes, E. S. (2010). Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. American journal of respiratory and critical care medicine, 182(11), 1344-1351. doi.org/10.1164/rccm.201001-0038pp

Malaja, L. T., Korzh, A. N., & Balkovaja, L. B. (2000). Jendotelial'naja disfunkcija pri patologii serdechno-sosudistoj sistemy. Har'kov: Torsing, 432 (in Russian).

Hall C. (2001). The value of natriuretic peptides for the management of heart failure: current state of play. European Journal of Heart Failure. 3(4): 395–397. doi.org/10.1016/s1388-9842(01)00151-9

Ashheulova, T. V., Kovaleva, O. N., Gerasimchuk, N. N., & Safargalina-Kornilova, N. A. (2016). Funkcional'noe sostojanie jendotelija i aktivnost' provospalitel'nyh citokinov u bol'nyh gipertonicheskoj bolezn'ju, associirovannoj s ozhireniem [Endothelial function and activity of proinflammatory cytokines in patients with hypertension associated with obesity]. Nauchnye Vedomosti Belgorodskogo Gosudarstvennogo Universiteta Medicina Farmacija, Aktual'nye problemy mediciny, 34(12 (233)), 5-14 (in Russian).

Ribeiro, F., Alves, A. J., Teixeira, M., Ribeiro, V., Duarte, J. A., & Oliveira, J. (2009). Endothelial function and atherosclerosis: circulatory markers with clinical usefulness. Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia= Portuguese journal of cardiology: an official journal of the Portuguese Society of Cardiology, 28(10), 1121-1151.

Lapshina, L. A., Molodan, V. I., Shevchenko, O. S., & Nemcova, V. D. (2001). Jendotelial'naja disfunkcija pri nachal'nyh stadijah arterial'noj gipertenzii i sposoby ee nemedikamentoznoj korrekcii. Ukrainskij terapevticheskij zhurnal, 3(4), 39 (in Russian).

Danilenko, S. A., & Landyshev, Ju. S. (2010). Mikrogemocirkuljatornye narushenija v slizistoj obolochke bronhov pri hronicheskoj obstruktivnoj bolezni legkih. Regionarnoe krovoobrashhenie i mikrocirkuljacija, 9(1), 38-41 (in Russian).

Van Suylen, R. J., Smits, J. F., & Daemen, M. J. (1998). Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension. American journal of respiratory and critical care medicine, 157(5), 1423-1428 (in Russian). doi.org/10.1164/ajrccm.157.5.9709050

Bakakos, P., Patentalakis, G., & Papi, A. (2016). Vascular Biomarkers in Asthma and COPD. Curr Top Med Chem. 16(14), 1599-1609. doi.org/10.2174/1568026616666150930121157

Shao, D., Park, J. E., & Wort, S. J. (2011). The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacological Research, 63(6), 504-511. doi.org/10.1016/j.phrs.2011.03.003

Almagro, P., Cabrera, F. J., Diez, J., Boixeda, R., Ortiz, M. B. A., Murio, C., & Soriano, J. B. (2012). Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPDComorbidity and Prognosis in COPD Hospitalized Patients The EPOC en Servicios de Medicina Interna (ESMI) Study. Chest Journal, 142(5), 1126-1133. doi.org/10.1378/chest.11-2413

Mannino, D. M., & Sanderson, W. T. (2017). Using big data to reveal chronic respiratory disease mortality patterns and identify potential public health interventions. Jama, 318(12), 1112-1114. doi.org/10.1001/jama.2017.11746

Ives, S. J., Harris, R. A., Witman, M. A., Fjeldstad, A. S., Garten, R. S., McDaniel, J., ... & Richardson, R. S. (2014). Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension, 63(3), 459-467. doi.org/10.1161/hypertensionaha.113.02255

Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003). Chronic obstructive pulmonary disease: molecular and cellularmechanisms. European Respiratory Journal, 22(4), 672-688. doi.org/10.1183/09031936.03.00040703

Makarova, M. A., Avdeev, S. N., & Chuchalin, A. G. (2014). Arterial'naja rigidnost' i jendotelial'naja disfunkcija u pacientov s hronicheskoj obstruktivnoj bolezn'ju legkih: chto pervichno? [Arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease: what is primary and secondary?] Pul'monologija, (6), 73-79 (in Russian). doi.org/10.18093/0869-0189-2011-0-6-73-79

Оеlsnеr, Е.C., Pоttingеr, T.D., Burkаrt, K.M., & Аllisоn, M. (2013). Аdhеsiоnmоlеculеs, еndоthеlin-1 аnd lung functiоni n sеvеn pоpulаtiоn-bаsеdcоhоrts. Biоmаrkеrs; 18 (3), 196–203.

Wаltеr, R.E., Wilk, J.B., Lаrsоn, M.G., & Vаsаn RS. (2008). Systеmic inflаmmаtiоn аnd CОPD: thе Frаminghаm Hеаrt Study. Chеst; 133 (1), 19–25.

Hе, Z. J. H., & Zhi, H. X. Z. (2010). Intеgrin-аssоciаtеd prоtеins in blооd plаsmа оf pаtiеnts with аcutееxаcеrbаtiоn оf chrоnic оbstructivе pulmоnаry disеаsе. Аrticlе in Chinеsе, 33(4), 265-7.

Riise, G. C., Larsson, S., Lofdahl, C. G., & Andersson, B. A. (1994). Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. European Respiratory Journal, 7(9), 1673-1677. doi.org/10.1183/09031936.94.07091673

Pollock, D. M. (2005). Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension, 45(4), 477-480.

Ashheulova, T. V., Zaika, M. V., & Gerasimchuk, N. N. (2007). Vzaimosvjaz' immunnoj aktivacii i oksidativnogo stressa pri progressirovanii arterial'noj gipertenzii. [The relationship between immune activation and oxidative stress in the progression of arterial hypertension]. Ukrainskij terapevticheskij zhurnal, 2, 12-15 (in Russian).

Barua, R. S., Ambrose, J. A., Eales-Reynolds, L. J., DeVoe, M. C., Zervas, J. G., & Saha, D. C. (2001). Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation, 104(16), 1905-1910. doi.org/10.1161/hc4101.097525

Butler, R., Morris, A. D., & Struthers, A. D. (2001). Cigarette smoking in men and vascular responsiveness. British journal of clinical pharmacology, 52(2), 145-149. doi.org/10.1046/j.0306-5251.2001.01434.x

Karoli, N. A., & Rebrov, A. P. (2004). Vlijanie kurenija na razvitie jendotelial'noj disfunkcii u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih. Pul'monologija, 2(14), 70-78.

Laurent, S., Katsahian, S., Fassot, C., Tropeano, A. I., Gautier, I., Laloux, B., & Boutouyrie, P. (2003). Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke, 34(5), 1203-1206. doi.org/10.1161/01.str.0000065428.03209.64

Mahendra, M., Kumar, S., Desai, N., Jayaraj, B. S., & Mahesh, P. A. (2018). Evaluation for airway obstruction in adult patients with stable ischemic heart disease. Indian heart journal, 70(2), 266-271. doi.org/10.1016/j.ihj.2017.08.003.

Ratova, L. G., Zykov, K. A., Dolgusheva, Ju. A., Agapova, O. Ju., Nazarov, B. M., & Chazova, I. E. (2012). Arterial'naja gipertonija i bronhoobstruktivnaja patologija-osobennosti klinicheskoj kartiny. Sistemnye gipertenzii, 9(1), 54–59. [Arterial'naya gipertoniya i bronkhoobstruktivnaya patologiya - osobennosti klinicheskoy kartiny] (in Russian). doi.org/10.26442/SG33169

Ovcharenko, S., I., Nersesyan, Z., N., & Morozova, T., E.. (2014). Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard) Systemic Hypertension, 11(2).54-58. doi.org/10.26442/sg29026

Triest, F. J., Studnicka, M., Franssen, F. M., Vollmer, W. M., Lamprecht, B., Wouters, E. F., ... & Vanfleteren, L. E. (2019). Airflow obstruction and cardio-metabolic comorbidities. COPD: Journal of Chronic Obstructive Pulmonary Disease, 16(2), 109-117. doi.org/10.1080/15412555.2019.1614550

Malo de Molina, R., Aguado, S., Arellano, C., Valle, M., & Ussetti, P. (2018). Ischemic heart disease during acute exacerbations of COPD. Medical Sciences, 6(4), 83. doi.org/10.3390/medsci6040083

Khassawneh, B. Y., Samrah, S. M., Jarrah, M. I., Ibdah, R. K., Ibnian, A. M., Almistarehi, A. W., ... & Khader, Y. S. (2018). Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan. International journal of chronic obstructive pulmonary disease, 13, 2759-2766. doi:10.2147/COPD.S172679 PMCID: PMC6130534.

Biscaglia, S., Ruggiero, R., Di Cesare, A., Serenelli, M., & Ferrari, R. (2019). Angina and chronic obstructive pulmonary disease: facing the perfect storm. European Heart Journal Supplements, 21(Supplement_C), 17-20. doi.org/10.1093/eurheartj/suz042

Almagro, P., De la Sierra, A., Acosta, E., Navarro, A., Garcia, M. E., Valdivieso, S., ... & Agustí, A. (2018). Spirometrically confirmed chronic obstructive pulmonary disease worsens long-term prognosis after percutaneous coronary intervention. American journal of respiratory and critical care medicine, 197(6), 824-826. doi.org/10.1164/rccm.201707-1389le

Andersson, C., Hansen, P. W., Steffensen, I. E., Andreasen, C., Weeke, P. E., Køber, L., ... & Torp-Pedersen, C. (2019). Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure–A danish nationwide registry-based study. European journal of internal medicine, 63, 56-61. doi.org/10.1016/j.ejim.2019.02.014

Bazargan, M., Smith, J. L., Robinson, P., Uyanne, J., Abdulrahoof, R., Chuku, C., & Assari, S. (2019). Chronic respiratory disease and health-related quality of life of African American older adults in an economically disadvantaged area of Los Angeles. International journal of environmental research and public health, 16(10), 1756. doi.org/10.3390/ijerph16101756

Ellingsen, J., Johansson, G., Larsson, K., Lisspers, K., Malinovschi, A., Ställberg, B., ... & Janson, C. (2020). Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD–Real-World Data from a Primary Care Setting. International journal of chronic obstructive pulmonary disease, 15, 235. doi: 10.2147/COPD.S231296.

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.